VIDEO: Use of AI to address health equity and health consumerization

AI is starting to be used in many applications to help increase access to higher value clinical care, even in remote, economically disadvantaged or resource poor areas. Examples include AI now being leveraged to help review and flag imaging exams in patient screening programs in developing countries where there are not enough physicians to review all the exams. It is also being used in rural clinics to help guide cardiac ultrasound exams or to offer initial clinical decision support for disease presentations that are not commonly seen.   

"What AI can do is augment your clinical decision support or your clinical pathways," Bogan explains. "In the future, we also will be less reliant on location. We will not need a clinic down the street because we will become more reliant on telehealth resources where physicians, or AI assisted physicians, will be able to help you."

He also said AI is helping healthcare systems address the growing demand for a more consumer-driven healthcare model, where care fits better with the patient's work or life schedule and there is less time waiting on hold.

"One of the things we need to be mindful of is that healthcare, like other industries, is going through a consumerization phase, where consumers and now demanding healthcare on their terms," Bogdan said. He explained AI can help with some areas of this process to reduce the number of staff needed to adjust to meet more immediate patient demands.

The U.S. Food and Drug Administration (FDA) has cleared more than 240 AI algorithms for use in healthcare to date, with many more pending final review. Bogdan said AI will be used to help augment staff shortages, streamline operations, data analytics, population health, scheduling, answering basic question and to flag critical findings for human doctors. He said AI is already being used across healthcare and it is expected to grow rapidly in the coming years. 

"If you don't have a strategy around artificial intelligence, there is a high likelihood you will be at a disadvantage, whether it is competitive or in producing the outcomes you are looking to produce in the health system," he explained. 

This is part of a 5-part series of interviews with Bogdan on various aspects of AI in healthcare. Here are the other videos in the series:

VIDEO: 9 key areas where AI is being implemented in healthcare

VIDEO: How hospital IT teams should manage implementation of AI algorithms

VIDEO: AI can help prevent clinician burnout

VIDEO: Understanding biases in healthcare AI

Find more AI news and video

Dave Fornell is a digital editor with Cardiovascular Business and Radiology Business magazines. He has been covering healthcare for more than 16 years.

Dave Fornell has covered healthcare for more than 17 years, with a focus in cardiology and radiology. Fornell is a 5-time winner of a Jesse H. Neal Award, the most prestigious editorial honors in the field of specialized journalism. The wins included best technical content, best use of social media and best COVID-19 coverage. Fornell was also a three-time Neal finalist for best range of work by a single author. He produces more than 100 editorial videos each year, most of them interviews with key opinion leaders in medicine. He also writes technical articles, covers key trends, conducts video hospital site visits, and is very involved with social media. E-mail: dfornell@innovatehealthcare.com

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.